Cargando…
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus
Gestational diabetes mellitus (GDM) is one of the most common metabolic diseases in pregnant women. Its early diagnosis seems to have a significant impact on the developing fetus, the course of delivery, and the neonatal period. It may also affect the later stages of child development and subsequent...
Autores principales: | Ruszała, Monika, Niebrzydowska, Magdalena, Pilszyk, Aleksandra, Kimber-Trojnar, Żaneta, Trojnar, Marcin, Leszczyńska-Gorzelak, Bożena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584125/ https://www.ncbi.nlm.nih.gov/pubmed/34769010 http://dx.doi.org/10.3390/ijms222111578 |
Ejemplares similares
-
Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0
por: Ruszała, Monika, et al.
Publicado: (2022) -
The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis
por: Kimber-Trojnar, Żaneta, et al.
Publicado: (2021) -
Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus
por: Pilszyk, Aleksandra, et al.
Publicado: (2022) -
Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
por: Pełech, Aleksandra, et al.
Publicado: (2023) -
Associations between Fatty Acid-Binding Protein 4–A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus
por: Trojnar, Marcin, et al.
Publicado: (2019)